Release Date: August 31, 2004
Notice Number: NOT-DK-04-013
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), (http://www.niddk.nih.gov/)
PurposeTo invite ideas for opportunities that can accelerate research progress and overcome current research barriers to the prevention, treatment and cure of type 1 diabetes and its complications. Background The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), leads a Special Statutory Funding Program ($150 million/year) for Type 1 Diabetes Research, on behalf of the Secretary of the Department of Health and Human Services. The special program supports research to pursue compelling opportunities in type 1 diabetes research (more information on the program can be found at: http://www.niddk.nih.gov/fund/diabetesspecialfunds/). The program is framed around six broad, scientific goals: Goal I: Identify the Genetic and Environmental Causes of Type 1 Diabetes Goal II: Prevent or Reverse Type 1 Diabetes Goal III: Develop Cell Replacement Therapy Goal IV: Prevent or Reduce Hypoglycemia Goal V: Prevent or Reduce the Complications of Type 1 Diabetes Goal VI: Attract New Talent and Apply New Technologies to Research on Type 1 Diabetes Information Requested The NIDDK invites submission of innovative ideas and approaches toward accelerating progress and overcoming research barriers to the prevention, treatment and cure of type 1 diabetes and its complications. There is significant flexibility in the use of the special funds; opportunities could be pursued through solicitations for traditional research grants or through mechanisms to support larger collaborative efforts. Suggestions should focus on identifying the opportunity and approaches, technology and expertise useful for its development rather than on a funding instrument or solicitation design. Suggestions that will involve creative scientists and scientific communities not currently working on type 1 diabetes, and with the potential to contribute to prevention, treatment and cure of type 1 diabetes, are particularly encouraged. Response and Process Submissions in response to this RFI will be considered by NIH and CDC scientists and by an ad hoc evaluation panel to be convened by the NIDDK as part of the process guiding use of the Special Statutory Funding Program for Type 1 Diabetes Research. This Request for Information is for information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the NIDDK. The NIDDK does not intend to award a grant or contract on the basis of responses nor otherwise pay for the preparation of any information submitted or the Government's use of such information. Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the Institute's evaluation of the information received. Responses will not be held in a confidential manner. Responses may be anonymous. Please describe your suggested opportunity or approach including: (1) how it could potentially have a major, positive impact on one or more of the six goals above, and/or (2) the current research barriers it could help overcome. You may submit more than one idea, but please limit the description of each to one page in length. For full consideration, submissions are due by Friday, October 22, 2004. For electronic submission, please visit the following website: http://www.niddk.nih.gov/forms/T1D-Opportunity.htm. For hard-copy submission, please mail or FAX your submission(s) to: Mary C. Hanlon, Ph.D.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.